A Preview Of Theravance Biopharma's Earnings
Portfolio Pulse from Benzinga Insights
Theravance Biopharma (NASDAQ:TBPH) is scheduled to release its quarterly earnings report on February 26, 2024, with an estimated EPS of $-0.15. Historically, the company has seen varied stock price reactions to its earnings performance, with a 5.34% increase following last quarter's beat. Over the past year, TBPH shares have declined by 18.75%, indicating a bearish sentiment among long-term shareholders.
February 23, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Theravance Biopharma is expected to report an EPS of $-0.15 for the upcoming quarter. Historical data shows stock price reactions to earnings announcements, with a notable 5.34% increase after last quarter's beat. However, the stock has declined 18.75% over the past year.
The expected EPS of $-0.15 sets a cautious tone for the upcoming earnings report. Historical performance shows that TBPH's stock price can react positively to earnings beats, as seen with the 5.34% increase after the last quarter's results. However, the overall yearly decline of 18.75% suggests a bearish long-term sentiment. The short-term impact on TBPH's stock price will likely depend on whether the company can beat the EPS estimate again and provide positive guidance for the future.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100